Enzalutamide

Trade Name: 
Xtandi
Manufacturer/Distributor: 
Astellas Pharma
www.astellas.ca
1-888-338-1824 (Medical information)
Classification: 
Antineoplastic agent
ATC Class: 
L02BB - anti-androgens
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2013/05/29
Date Marketed in Canada (yyyy/mm/dd): 
2013/06/07
Presentation: 
Capsule: 40 mg. DIN: 02407329
Comments: 
For the treatment of patients with metastatic castration-resistant prostate cancer in the setting of medical or surgical castration who have received docetaxel therapy.